Suzhou Lixin Pharmaceutical Co., Ltd is dedicated in the manufacturing active pharmaceutical ingredients (APIs)and High-added-value intermediates. In pursuit of regulated API market in and out of China since its establishment, lixin has built GMP certificated workshops, Chemical Synthesis Workshops, facilities, and established standard quality management system and advanced quality control profile.

Oriented at international market of APIs and intermediate materials, Lixin has built strong cooperation with domestic and international pharmaceutical companies. With the innovation of production process and patent protection, it already has series of APIs including  anti-tumor drugs, cardiovascular drugs and so on.　In order to obtain favorable comments from customers on our high-quality products and standard quality management system, Lixin insists studying the process and  product quality under the guidelines of ICH and the rules of SFDA.

Lixin possesses a team of chemical scientists and managers engaged in the pharmaceutical industry for decades of years. They strive to make innovations in new products research, development, technology improvement, quality control,quality management, product sales and service, etc.

Suzhou Lixin Pharmaceutical Co.,Ltd aims to provide high-quality products and services with science and technology innovation to

customers.